There are approximately 300 million cases of malaria each year, with nearly 1 million deaths occurring mostly in children living in sub-Saharan Africa. The impact of malaria on maternal-child health cannot be overestimated. In Ghana and several sub-Saharan countries, malaria is the leading cause of morbidity, accounting for up to 37.5% of all outpatient visits annually. It is also the leading cause of mortality in children under five years, a significant cause of adult morbidity, and the leading cause of lost income due to illness. Thus, the burden of malaria in sub-Saharan Africa is both a cause and result of poverty, with a negative economic impact of approximately $12 billion annually. Effective control or elimination of malaria would have a significant and lasting beneficial effect on the quality of life and economic outlook for sub-Saharan Africa.
The HopeXchange Malaria Center has three goals:
- To improve outcomes for children and adults with malaria by enhancing clinical capacity and access to state of the art medical care in Ghana
- To sponsor cutting edge collaborative research aimed at developing innovative methods to prevent, treat, and ultimately eradicate malaria in sub-Saharan Africa
- To develop a global network of partner institutions committed to supporting the clinical, educational, and research mission of HopeXchange
A comprehensive and high-impact malaria control program will be seamlessly integrated into the existing HopeXchange infrastructure, thereby allowing for rapid scale-up of individual initiatives aimed at achieving the above stated goals. Because HopeXchange has already established deep ties to the local community and thanks to existing collaborative relationships with international partners in Italy, Austria and the United States, as well as the leading Tropical Diseases research institute in Ghana, the necessary infrastructure is already in place to establish HopeXchange as a premiere hub for malaria research in sub-Saharan Africa.